A patient with chronic lymphocytic leukemia (CLL) will imminently begin a course of treatment with rituximab. In order to minimize the risk of adverse effects, what strategy for administration will be adopted?
A) Admitting the patient to the intensive care unit in anticipation of the initial bolus of the drug
B) Administering diphenhydramine 30 minutes prior to the initial dose of rituximab
C) Administering the drug by slow infusion to two peripheral IV sites simultaneously
D) Administering the initial doses by slow infusion while observing for adverse reactions
Question 2
A nurse has completed a medication reconciliation of a patient who has been admitted following a motor vehicle accident. Among the many drugs that the patient has received in the previous year is rituximab.
The nurse would be justified in suspecting the patient may have received treatment for which of the following diseases?
A) Non-Hodgkin's lymphoma
B) Malignant melanoma
C) Nonsmall cell lung cancer
D) Renal cell carcinoma
The patient interview often requires note taking.
Providing patient education
A goniometer is used to measure range of motion of the patient’s arm.
A partnership between the patient and the health care provider.
Colorimetric multiplex assay to determine anti-HLA antibodies in a patient's serum.
Head of a patient with tertiary syphilis.